Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -0.1% | -38.6% | 0 / 3 | +11.2% | +1.40 pp | +0.31 pp | +2.5% | 1.11 | 16.46 | 516 | +11,2% | 3,7 | +95,0% | 16.46 | 16.49 | −0,2% |
| Pts | 0 | 0 | 0 | 4 | 8 | 8 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 4.100 (close price on 2026-10-16)EPS (TTM): 249,1
Financial charts
1.Revenue & growth
VND bn515Q2/26
1.Revenue & growth
VND bn515Q2/26
2.Profit & growth
VND bn3,32Q2/26
3.Profit mix (Penman)
VND bn7,50Q2/26
4.Margins & cost structure
%1.7%Q2/26
5.Returns & cash cycle
% · days3.5%Q2/26
6.Earnings quality & cash
VND bn-55,9Q2/26
7.Asset structure
VND bn754Q2/26
8.Funding & debt health
VND bn · times754Q2/26
9.Revenue backlog
VND bn9,45Q2/26
10.Valuation
times · %21,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %108Q2/26
Adjusted EPS growth, latest quarter
-10.6%
Average adjusted EPS growth, 3 quarters
-42.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
95.2%
Source: vnstockData through Q2/26